Nordic rights to ReFacto and BeneFIX are returned to Pfizer - 17-Feb-2012

Phase III trial for N9-GP(Novo Nordisk) treatment for Haemophilia B

FDA accepts BLA from Biogen for Eloctate for treatment of Haemophilia A

Biogen IDEC files rFVIII Fc at FDA for treatment of Haemophilia A

FDA expands approval of Corifact (CSL Behring) to manage surgical bleeding in adult and pediatric patients with Factor XIII Deficiency

Successful studies for rFVIIIFc and rFIXFc (Biogen/Swedish Orphan) for Haemopilia

BAX 855 enters Phase II/III study for Haemophilia

Biogen Idec files rFIXFc at FDA for treatment of Haemophilia B

Phase III results for BAX 326 (Baxter) for Haemophilia B

View all

Haematology Clinical Guidelines

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Aidsinfo

British HIV Association guidelines for the treatment of TB/HIV coinfection 2011

British HIV Association

View all

Haematology Clinical Trials

Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (DASAPOST)

Clinicaltrials.gov 27 February 2013

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis

Clinical Trials Register.eu 05 February 2013

View all

Haematology Medical Journal Abstracts

PedsQL™ Sickle Cell Disease Module: Feasibility, Reliability, and Validity

Pediatric Blood & Cancer 25 February 2013

Validation of Variants in SLC28A3 and UGT1A6 as Genetic Markers Predictive of Anthracycline-Induced Cardiotoxicity in Children

Pediatric Blood & Cancer 25 February 2013

View all

Haematology Medical Apps

The Oncologist

Free

ACP PIER Database - Hematology

£37.29